Diabetic Retinopathy Screening Ratio Is Improved When Using a Digital, Nonmydriatic Fundus Camera Onsite in a Diabetes Outpatient Clinic
Table 3
Baseline parameters of prevalence and severity of retinopathy in persons with type 2 diabetes ().
Characteristics
DM 2 ()
DR preexisting = 60 (15.4%)
DR new = 26 (6.7%)
DR all = 86 (22.1%)
DR absent = 304 (77.9%)
Gender, (%)
Male
196 (50.3%)
29 (48.3%)
14 (53.8%)
43 (50%)
153 (50.3%)
Female
194 (49.7%)
31 (51.7%)
12 (46.2%)
43 (50%)
151 (49.7%)
Age, y
65 ± 12
71 ± 9
66 ± 11
69 ± 9
64 ± 12
<
Age, (%)
60 years
129 (33.1%)
9 (15.0%)
10 (38.5%)
19 (12.8%)
110 (74.3%)
80 years
41 (10.5%)
11 (18.3%)
3 (11.5%)
14 (25.5%)
27 (49.1%)
Diabetes duration, y
14 ± 10
24 ± 10
18 ± 11
22 ± 10
11 ± 8
<
<
10 years, (%)
166 (42.6%)
4 (6.7%)
5 (19.2%)
9 (10.5%)
157 (51.6%)
<
11–19 years, (%)
133 (34.1%)
16 (26.7%)
13 (50.0%)
29 (33.7%)
104 (34.2%)
20 years, (%)
91 (23.3%)
40 (66.7%)
8 (30.8%)
48 (55.8%)
43 (14.1%)
<
Median time to last eye screening (months)
9 ± 13
5 ± 12
11 ± 11
7 ± 12
10 ± 13
Hypertension, (%)
347 (89.0%)
59 (98.3%)
24 (92.3%)
83 (96.5%)
264 (86.8%)
Antidiabetic treatment, (%)
Lifestyle
34 (8.7%)
1 (1.7%)
2 (7.7%)
3 (3.5%)
31 (10.2%)
Oral agents
261 (66.9%)
28 (46.7%)
19 (73.1%)
47 (54.7%)
214 (70.4%)
Insulin treatment
197 (50.5%)
52 (86.7%)
19 (73.1%)
71 (82.6%)
126 (41.4%)
<
Statin therapy
237 (60.8%)
41 (68.3%)
19 (73.1%)
60 (69.8%)
177 (58.2%)
0.14
HbA1c (%)
7.3 ± 1.5
7.8 ± 1.5
8.4 ± 2.0
8.0 ± 1.7
7.1 ± 1.5
<
DR = diabetic retinopathy. HDL = high density lipoprotein, LDL = low density lipoprotein. = value DR preexisting versus DR new. = value DR all versus DR absent. = value DR new versus DR absent. Chi-square test (-test). -test.
